• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏植入式电子设备患者中无感染的铅块的流行率和预后。

Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection.

机构信息

Division of Cardiology, Department of Internal Medicine, University of Turin, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

出版信息

J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):372-378. doi: 10.2459/JCM.0000000000000797.

DOI:10.2459/JCM.0000000000000797
PMID:30950985
Abstract

BACKGROUND

Finding of intracardiac lead masses in patients with cardiac implantable electronic devices remains controversial, as such masses have been observed in cases of exclusively local infections whereas they have not been recognized in patients with positive cultures of intravascular lead fragments. In this study, we aim to describe the prevalence of intracardiac lead masses in true asymptomatic patients with cardiac implantable electronic devices, to identify their predictive factors and to define their prognostic impact at long-term follow-up.

METHODS

Seventy-eight consecutive patients admitted over a 6-month period for elective generator replacement without clinical evidence of infection were evaluated by transthoracic and transesophageal echocardiography and prospectively followed at in-clinic follow-up visits.

RESULTS

Lead masses were found in 10 patients (12.8%). These patients had more frequently right ventricular dysfunction at univariate analysis (OR 2.71, P = 0.010) and after baseline variables adjustment (hazard ratio 6.25, P = 0.012). At 5-year follow-up without any specific therapy, none of the patients suffered from any cardiac device infections, or developed clinical signs of infections.

CONCLUSION

There is an evidence of clinical lead masses in asymptomatic patients with cardiac implantable electronic devices. The value of these findings is still debated for aetiological interpretation and for therapeutic strategy, but they are not necessarily associated with an infection.

摘要

背景

在患有心脏植入式电子设备的患者中发现心内导线肿块仍然存在争议,因为这种肿块仅在局部感染的情况下观察到,而在血管内导线碎片培养阳性的患者中未发现。在这项研究中,我们旨在描述真正无症状的患有心脏植入式电子设备的患者中心内导线肿块的患病率,确定其预测因素,并定义其在长期随访中的预后影响。

方法

在 6 个月的时间内,连续有 78 例因选择性发电机更换而入院的患者,无感染的临床证据,通过经胸和经食管超声心动图进行评估,并在门诊随访中进行前瞻性随访。

结果

10 例患者(12.8%)发现导线肿块。在单变量分析中(OR 2.71,P = 0.010)和在基线变量调整后(风险比 6.25,P = 0.012),这些患者更频繁地出现右心室功能障碍。在没有任何特定治疗的 5 年随访中,没有患者发生任何心脏设备感染或出现感染的临床迹象。

结论

在无症状的患有心脏植入式电子设备的患者中存在临床导线肿块的证据。这些发现的价值对于病因学解释和治疗策略仍然存在争议,但它们不一定与感染有关。

相似文献

1
Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection.心脏植入式电子设备患者中无感染的铅块的流行率和预后。
J Cardiovasc Med (Hagerstown). 2019 Jun;20(6):372-378. doi: 10.2459/JCM.0000000000000797.
2
Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.心血管植入式电子设备植入术后感染及相关费用:一项全国性队列研究。
Europace. 2018 Dec 1;20(12):1974-1980. doi: 10.1093/europace/eux387.
3
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.感染性心内膜炎与心脏植入式电子设备植入术后死亡风险:一项全国性队列研究。
Europace. 2017 Jun 1;19(6):1007-1014. doi: 10.1093/europace/euw404.
4
Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.经静脉导线拔除术后 30 天和 1 年死亡率的预测因素:单中心经验。
Europace. 2014 Aug;16(8):1218-25. doi: 10.1093/europace/eut410. Epub 2014 Feb 25.
5
CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.具有囊袋或全身感染表现的心脏植入电子设备(CIED)感染——完全移除设备并进行长期抗生素治疗;长期预后。
Scand Cardiovasc J. 2016;50(1):52-7. doi: 10.3109/14017431.2015.1091089. Epub 2015 Oct 20.
6
Device-Pocket Hematoma After Cardiac Implantable Electronic Devices.心脏植入式电子设备后的设备囊袋血肿
Circ Arrhythm Electrophysiol. 2020 Apr;13(4):e008372. doi: 10.1161/CIRCEP.120.008372. Epub 2020 Mar 20.
7
Diagnosis of cardiac device-related infective endocarditis after device removal.心脏装置移除后与装置相关感染性心内膜炎的诊断。
JACC Cardiovasc Imaging. 2010 Jul;3(7):673-81. doi: 10.1016/j.jcmg.2009.12.016.
8
Same-day contralateral implantation of a permanent device after lead extraction for isolated pocket infection.同期行永久性心脏起搏器同侧植入术治疗孤立性囊袋感染导致的导线拔除术后感染。
Europace. 2014 Feb;16(2):252-7. doi: 10.1093/europace/eut220. Epub 2013 Jul 31.
9
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.需要手术修正的植入式设备并发症的发生率、原因及其对患者预后的影响:来自意大利两个中心的大型人群调查。
Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13.
10
Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram.经食管超声心动图定义的 100 例心内膜赘生物患者的经皮起搏器和植入式心脏复律除颤器导线拔除术。
J Am Coll Cardiol. 2010 Mar 2;55(9):886-94. doi: 10.1016/j.jacc.2009.11.034.

引用本文的文献

1
What Important Information Does Transesophageal Echocardiography Provide When Performed before Transvenous Lead Extraction?经静脉导线拔除术前行经食管超声心动图检查能提供哪些重要信息?
J Clin Med. 2024 Sep 5;13(17):5278. doi: 10.3390/jcm13175278.
2
Novel Hematological Parameters in the Assessment of the Extent of Cardiac Implantable Electronic Device-Related Infections.用于评估心脏植入式电子设备相关感染程度的新型血液学参数
J Clin Med. 2023 Dec 4;12(23):7498. doi: 10.3390/jcm12237498.
3
Evaluation of lead-based echodensities on transesophageal echocardiogram in patients with cardiac implantable electronic devices.
经食管超声心动图检查中心脏植入式电子设备患者的基于铅的回声密度评估。
J Cardiovasc Electrophysiol. 2023 Jan;34(1):7-13. doi: 10.1111/jce.15727. Epub 2022 Nov 6.
4
"Ghost", a Well-Known but Not Fully Explained Echocardiographic Finding during Transvenous Lead Extraction: Clinical Significance.“幽灵”:经静脉心内膜导线拔除术中一种众所周知但尚未完全阐明的超声心动图表现:临床意义
Int J Environ Res Public Health. 2022 Oct 1;19(19):12542. doi: 10.3390/ijerph191912542.
5
Imaging of Cardiac Device-Related Infection.心脏装置相关感染的影像学检查
Front Cardiovasc Med. 2021 Aug 24;8:729786. doi: 10.3389/fcvm.2021.729786. eCollection 2021.
6
The role of transesophageal echocardiography in predicting technical problems and complications of transvenous lead extractions procedures.经食管超声心动图在预测经静脉导线拔除术技术问题和并发症中的作用。
Clin Cardiol. 2021 Sep;44(9):1233-1242. doi: 10.1002/clc.23660. Epub 2021 Jul 24.
7
The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle.经静脉导线拔除术后经食管超声心动图的预后价值:战斗后的景象
Cardiovasc Diagn Ther. 2021 Apr;11(2):394-410. doi: 10.21037/cdt-20-871.
8
Prognostic Value of Preoperative Echocardiographic Findings in Patients Undergoing Transvenous Lead Extraction.经静脉导线拔除术患者术前超声心动图检查结果的预后价值。
Int J Environ Res Public Health. 2021 Feb 14;18(4):1862. doi: 10.3390/ijerph18041862.
9
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).欧洲心脏病学会(EHRA)关于如何预防、诊断和治疗心脏植入式电子设备感染的国际共识文件——得到了心律学会(HRS)、亚太心律学会(APHRS)、拉丁美洲心律学会(LAHRS)、心血管感染性疾病国际学会(ISCVID)和欧洲临床微生物学和传染病学会(ESCMID)的认可,该共识文件是与欧洲心胸外科学会(EACTS)合作制定的。
Europace. 2020 Apr 1;22(4):515-549. doi: 10.1093/europace/euz246.